Skip to content

Etiological Surveillance, Early Warning and Novel Therapies for Pediatric Acute Lower Respiratory Tract Infections

Etiological Surveillance, Early Warning and Novel Therapies for Pediatric Acute Lower Respiratory Tract Infections

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122328
Enrollment
Unknown
Registered
2026-04-12
Start date
2026-04-12
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lower respiratory tract infection, Mycoplasma pneumoniae pneumonia

Interventions

Azithromycin Group:Azithromycin administration
Doxycycline Group:Doxycycline medication

Sponsors

Beijing Childrens Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Children diagnosed with mycoplasma pneumonia according to the "Diagnosis and Treatment Guidelines for Mycoplasma Pneumonia in Children (2025 Edition)" and the "Expert Clarification on Diagnosis and Treatment of Mycoplasma Pneumonia in Children"; 2. Age >= 8 years old; 3. Duration of illness <= 5 days

Exclusion criteria

Exclusion criteria: 1.Antibiotics such as tetracyclines and quinolones have been administered outside the hospital for treatment; 2.Those who did not respond after 72 hours of treatment with azithromycin should be given further treatment; 3.Those who are allergic to the drugs used in this study; 4.Those with combined immunodeficiency diseases or other underlying diseases such as lung, liver, kidney or heart disorders; 5.Those who have combined infections; 6.Clinical phenotype: critical; 7.Those with poor compliance or the patients and their guardians do not agree to participate in this stud;

Design outcomes

Primary

MeasureTime frame
The incidence of post-treatment pulmonary sequelae on the 90th day;Drug conversion rate;

Secondary

MeasureTime frame
Number of days after medication when fever subsides;The number of days for the disappearance of respiratory symptoms and signs;Whether the lung images have completely absorbed and the number of days for absorption;The frequency of bronchoscopy and the characteristics of bronchoscopy under endoscopy;Hospitalization expenses;Length of hospital stay;

Countries

China

Contacts

Public ContactYang Haiming

Beijing Childrens Hospital,Capital Medical University

yanghaiming830@163.com+86 10 58531216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026